Adenosine 3 mg/mL (2 mL) is a sterile, preservative‑free single‑dose injection supplied in a sealed vial for immediate, one‑time use during acute supraventricular tachycardia management by qualified clinicians. The standardized concentration supports rapid administration within oral and maxillofacial and general dental practice environments that maintain advanced emergency preparedness capabilities. The single‑dose format ensures strict aseptic integrity and eliminates the risks associated with repeated vial entry. Clear labeling, lot traceability, and USP‑compliant manufacturing promote accuracy and dependable performance during high‑acuity cardiovascular events. This product is repackaged and fully DSCSA compliant, ensuring secure supply‑chain handling and documentation.